Comparison of the major flavonoid content of S. baicalensis, S. lateriflora, and their commercial products

Journal of Natural Medicines

Volumn 62, Issue 3, 2008, Pages 294-299

  Makino, Toshiaki ^a   Hishida, Atsuyuki ^b   Goda, Yukihiro ^c   Mizukami, Hajime ^a  

^a NAGOYA CITY UNIVERSITY   (Japan)

^b Research Center for Medicinal Plant Resources   (Japan)

^c NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

Author keywords

Baicalin; Dietary supplement; Kampo medicine; Scutellaria baicalensis; Scutellaria lateriflora; Wogonin

Indexed keywords

BAICALEIN; BAICALIN; FLAVONOID; PLANT EXTRACT; SCUTELLARIA BAICALENSIS EXTRACT; SCUTELLARIA LATERIFLORA EXTRACT; WOGONIN; WOGONIN 7 O GLUCURONIDE;

ARTICLE; DIET SUPPLEMENTATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MEDICINAL PLANT; PLANT ROOT; SCUTELLARIA; SCUTELLARIA LATERIFLORA;

DIETARY SUPPLEMENTS; FLAVANONES; FLAVONOIDS; GLUCURONIDES; JAPAN; PLANT EXTRACTS; PLANT LEAVES; PLANT ROOTS; PLANT STEMS; SCUTELLARIA; SCUTELLARIA BAICALENSIS; TEA;

EID: 44949110136     PISSN: 13403443     EISSN: 18610293     Source Type: Journal    
DOI: 10.1007/s11418-008-0230-7     Document Type: Article

References (13)

1. The Society of Japanese Pharmacopoeia (2007) The Japanese pharmacopoeia (JP XV), 15th edn. Yakuji-Nippo, Tokyo
2. The Japan Society for Oriental Medicine (2005) Introduction to KAMPO. Elsevier, Tokyo
3. Tsao TF, Newman MG, Kwok YY, Horikoshi AK (1982) Effect of Chinese and western antimicrobial agents on selected oral bacteria. J Dent Res 61:1103-1106
4. Huang WH, Lee AR, Yang CH (2006) Antioxidative and anti-inflammatory activities of polyhydroxyflavonoids of Scutellaria baicalensis GEORGI. Biosci Biotechnol Biochem 70:2371-2380
5. Park S, Hahm KB, Oh TY, Jin JH, Choue R (2004) Preventive effect of the flavonoid, wogonin, against ethanol-induced gastric mucosal damage in rats. Dig Dis Sci 49:384-394
6. Itoh Y, Sendo T, Oishi R (2006) Drug-induced hepatopathy. Folia Pharmacol Jpn 127:425-432
7. Yafune A, Tsutani K (1996) Hepatic injury induced by Scutellaria species and hepatic dysfunction caused by kampo formulations including ogon (Scutellariae Radix). Jpn J Clin Pharmacol Ther 27:635-345
8. Terada M, Kitazawa H, Kawakami J, Adachi I (2002) Pharmacoepidemiology of interstitial pneumonia and liver dysfunction associated with kampo medicine. Jpn J Pharm Health Care 28:425-434
9. Nakazawa Y, Suzuki S, Negichi E, Nakazaki M, Ueno K, Akiba T (2006) Investigation of changes in ALT levels after administration of kampo medicines at Akiba hospital. Jpn J Pharm Health Care 32:504-510
10. Ministry of Health, Labour and Welfare of Japan (2001) Notification No. 243 (March 27, 2001) from Director-General of the Pharmaceutical and Food Safety Bureau, MHLW; partially revised by Notification No. 1115003 (April 17, 2007)
11. Lininger SW, Gaby AR, Austin S, Brown DJ, Wright JV, Duncan A (2000) The natural pharmacy. Random House, NY
12. Ishimaru K, Nishikawa K, Omoto T, Asai I, Yoshihira K, Shimomura K (1995) Two flavone 2′-glucosides from Scutellaria baicalensis. Phytochemistry 40:279-281
13. American Herbal Products Association (1997) Botanical safety handbook. CRC Press, Boca Raton